Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
August 29, 2026
AskBio Presents Baseline Characteristics from Phase 2 Heart Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at European Society of Cardiology Congress
August 28, 2026
Not intended for U.S. and UK Media
Bayer submits application in Japan for expanded use of Kerendia in chronic kidney disease therapeutic area
August 24, 2026
Not intended for U.S. and UK Media
Bayer’s sevabertinib approved in Japan for patients with HER2-mutant non-small cell lung cancer
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
